1. Home
  2. CSV vs DSGN Comparison

CSV vs DSGN Comparison

Compare CSV & DSGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carriage Services Inc.

CSV

Carriage Services Inc.

N/A

Current Price

$43.32

Market Cap

659.5M

ML Signal

N/A

Logo Design Therapeutics Inc.

DSGN

Design Therapeutics Inc.

N/A

Current Price

$10.33

Market Cap

579.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CSV
DSGN
Founded
1991
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
659.5M
579.9M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
CSV
DSGN
Price
$43.32
$10.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$59.00
$15.25
AVG Volume (30 Days)
69.8K
245.5K
Earning Date
04-29-2026
03-09-2026
Dividend Yield
1.04%
N/A
EPS Growth
54.76
N/A
EPS
3.25
N/A
Revenue
$417,440,000.00
N/A
Revenue This Year
$7.35
N/A
Revenue Next Year
$3.87
N/A
P/E Ratio
$13.24
N/A
Revenue Growth
3.28
N/A
52 Week Low
$35.51
$2.62
52 Week High
$49.41
$11.23

Technical Indicators

Market Signals
Indicator
CSV
DSGN
Relative Strength Index (RSI) 49.04 51.24
Support Level $40.85 $9.64
Resistance Level $44.47 $11.18
Average True Range (ATR) 1.11 0.58
MACD -0.06 -0.02
Stochastic Oscillator 48.70 42.86

Price Performance

Historical Comparison
CSV
DSGN

About CSV Carriage Services Inc.

Carriage Services Inc is a provider of funeral and cemetery services and merchandise in the United States. It operates in two business segments: The Funeral Home Operations segment offers burial, cremation, and consultation services; removes and prepares remains; sells caskets, urns, and related funeral merchandise. The company enables the use of funeral home facilities for visitation, remembrance, and transportation services. The Cemetery Operations segment provides services, such as mausoleum spaces and niches, private estates, lawn crypt gardens, traditional single burial gravesites, and burial vaults. The majority of revenue is derived from The Funeral Home Operations segment.

About DSGN Design Therapeutics Inc.

Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.

Share on Social Networks: